c a n a d a h o u s e wellness group inc. Investment Summary CSE: CHV April 2019 canadahouse.ca
DISCLAIMER This presentation contains historical and forward-looking statements. The forward- looking statements involve risks and uncertainties. Forward looking statements appearing in this presentation represent management’s current estimates and these may change significantly as new information comes to hand. The information contained in this presentation has been obtained by Canada House Wellness Group Inc. from its own records and from other sources believed to be reliable, however no representation or warranty is made as to its accuracy or completeness. Reference should be made to the Company’s most recent annual audited Financial Statements and Management's Discussion and Analysis for the Year Ending April 30, 2018 as well as more recent quarters in Fiscal 2019, as filed with Canadian securities regulatory authorities (and available at www.sedar.com) for a description of the major risk factors. CSE: CHV 2
WHO WE ARE Canada House Wellness Group (“CHV” trading on the Canadian Securities Exchange under ticker “CHV”) delivers quality cannabis and care to discerning consumers in global medical and recreational markets. It is a Veteran-founded, experienced medical cannabis group providing patient-specific cannabinoid therapy products and services through its clinics and licensed producer. It also leverages its indoor grow expertise to provide premium craft cannabis to the adult use market. c a n a d a h o u s e wellness group inc. LICENSED CLINICS PRODUCER CSE: CHV 3
OUR MISSION c a n a d a h o u s e wellness group inc. We Help Renew Lives TM through patient-specific cannabinoid therapy and the production of the highest quality cannabis-based medication. We curate premium craft cannabis for discerning adult use with our specialized, quality-focused, indoor grow production. CSE: CHV 4
THE MARKET c a n a d a h o u s e wellness group inc. Canada is the strongest cannabis market in the world: First G7 nation to legalize cannabis • World-class framework for cannabis production standards • Market value: Canadian medical market ($2.8B) 1 • EU medical market ( € 3.4B) 2 • Total Canadian adult use ($3.1B) 3 • Global total addressable market (TAM) exceeding $100B 4 : • Blue Sky in C$ bns Scenario 1 Scenario 2 Scenario 3 Scenario 4 Scenario 5 Canada Canada Canada Canada US Medical Canada US US US EU-28 Germany EU-28 EU-28 LATAM Canada Canada Canada Canada Adult-use Canada US US US US EU-28 EU-28 TAM $5.9 $79 $104 $172 $194 CSE: CHV 5 See references in Appendix on slide 29.
OUR INTEGRATED STRATEGY c a n a d a h o u s e wellness group inc. CLINICS Continue to provide leading cannabinoid therapy services to retain and grow our valuable patient base via: • An expert team of healthcare professionals • Patient-specific treatment protocols • Prescription and LP registration services CULTIVATION Produce top quality medical cannabis strains for our patients and offer advanced consulting to the industry using: Grow • Industry-leading cultivation methodologies and regulatory expertise • Highly educated and experienced cultivation staff • Access to 800+ cannabis strains Retail RECREATIONAL / HEALTH & WELLNESS Distribute craft cannabis products to recreational market: Oil and edibles lab being built with strategic partner • First dispensary to open in Edmonton, Alberta • CSE: CHV 6
READY TO GROW c a n a d a h o u s e PATH TO PROFITABILITY wellness group inc. CULTIVATION & PROCESSING CLINICS Cultivate premium craft cannabis focused Grow national patient base • • on medical patients using proprietary Expand and physician referrals • growing methodology Leading custom-built Cannabis • Extraction lab for oils, edibles, and health & • Patient Management EMR platform wellness products Provide consulting services for micro-growers • HOUSE OF BRANDS GENETICS Leverage our cultivation and processing Supply recreational and medical markets with • to develop House of Brands for premium seeds from top international breeders distribution in medical, recreational, and and premium genetics from the in-house health & wellness segments globally breeding program. Brands will be developed in-house, • acquired, or through licensing or JV CSE: CHV partnership opportunities 7
Canada House Clinics (CHC) is the leading provider of specialized cannabinoid therapy services to patients suffering from common to CLINICS complex medical conditions. Valuable client base that orders directly from LPs • 98% of Revenues are LP Education fees • 35%+ clinic market share of Veteran medical cannabis program 5 • Average monthly revenues over $70/client/month • 12 5,200+ 2,400+ 25+ 12,000+ 2,700+ kgs clinics total patients fully insured LP partners historical of annual nationwide with active patients and growing registrations managed med docs (Veterans) cannabis consumption CSE: CHV 8 See references in Appendix on slide 29.
CLINICS REVENUE MODEL 1. Patient registers 2. Clinics educate patients and help with Clinics choose a Licensed Producer for most effective strain +20 others 3. Licensed Producer pays clinic a service and education fee 9
CLINICS DIFFERENTIATOR TECHNOLOGY Knalysis Technologies: CHV-owned, CHC-led, software firm with proprietary patient management software and AI analytics. It supports CHC in Canada and global clients to obtain and retain patients while giving them a best-in-class experience. Data-driven Secure CPM 2.0 launched analysis enables Telemedicine March 2019. condition- integrated into Next generation specific and CPM 2.0 with Cannabis Patient patient-specific physician and Management strain selection patient portals software. CSE: CHV 10
CLINICS DIFFERENTIATOR VETERAN RELATIONSHIPS CHC Founders created Veteran Total Veteran clients over time • cannabis market Government funds cannabis for • Veterans diagnosed with PTSD and other awarded conditions Support beyond cannabis with non- • profit Post-Traumatic Growth Association (PTGA) Per client revenue 4-6 times higher • than standard Steady Veteran client growth for CHC • Jan. 2018 April 2018 July 2018 Oct. 2018 Jan. 2019 CSE: CHV 11
Abba Medix is a fully licensed and CULTIVATION operational Licensed Producer with an active production facility in Pickering, & PROCESSING c a n a d a Ontario and 180,000+ sq ft. of secured h o u s e production space in Alberta and Ontario. wellness group inc. Cannabis ~40,000 kg of Medicine Man Fully operational Pursuing 180,000 sq ft Cultivation , secured Technologies’ LP with first full EU-GMP production Processing , and production (MDCL) proven commercial- certification facility, Phase 1 Sales Licenses capacity production scale harvest allowing for expected to be from Health methodology expected in sales to high- operational Canada exclusively licensed Mid-2019 value EU before FYE 2020 in Canada market CSE: CHV 12
PRODUCTION RAMP UP c a n a d a h o u s e wellness group inc. 40,000 Total production (kgs) 6,500 2,500 PICKERING VEGREVILLE PHASE 1 VEGREVILLE PHASE 2 TOTAL + + = 2,000 – 3,000 kg 3,000 – 5,000 kg ~ 27,000 – 35,000 kg ~40,000 kg/yr Mid-2019 Mid-2020 Mid-2021 CSE: CHV 13
Canada House of Brands is focused on product HOUSE OF development and will market and sell craft BRANDS cannabis to the medical, recreational, and c a n a d a health & wellness markets globally. Its first h o u s e dispensary will be located in Edmonton. wellness group inc. Dispensary Oils and edibles Product Pursuing provincial license lab being built development for supply agreements, awarded in with strategic medical, bulk transfer Edmonton, partner recreational, and opportunities and Alberta health & high-value EU wellness markets distribution channels CSE: CHV 14
KEY PARTNERSHIPS c a n a d a h o u s e wellness group inc. Licensing agreement with Joint venture with MOU with University Medicine Man Technologies Nutritional High of New Brunswick Exclusive Canadian licensing Produce medical-grade Potential areas of collaboration agreement for: Abba Medix extracts to between Canada House serve both the medical and UNB include: Success Nutrients • and recreational markets. Three a Light grow • Education • methodologies Technology platforms • Analytics, clinical and • medical research Plant research and • genomics CSE: CHV 15
MEDICAL c a n a d a ADVISORY BOARD h o u s e wellness group inc. Provides guidance on ethics and • best practices Provide medical leadership • across CHV Membership from physicians • prescribing cannabis for Canada House Clinics and external physicians with key expertise 4 physicians growing to 6 as • board formalizes in 2019 CSE: CHV 16
Recommend
More recommend
